Contrasting Phreesia (NYSE:PHR) & EUDA Health (NASDAQ:EUDA)

EUDA Health (NASDAQ:EUDAGet Free Report) and Phreesia (NYSE:PHRGet Free Report) are both small-cap real estate companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings and dividends.

Valuation & Earnings

This table compares EUDA Health and Phreesia”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
EUDA Health $6.82 million 8.41 -$2.77 million N/A N/A
Phreesia $480.59 million 1.38 $2.31 million $0.15 71.51

Phreesia has higher revenue and earnings than EUDA Health.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for EUDA Health and Phreesia, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
EUDA Health 1 1 1 0 2.00
Phreesia 1 9 9 0 2.42

EUDA Health currently has a consensus price target of $55.00, suggesting a potential upside of 187.13%. Phreesia has a consensus price target of $16.65, suggesting a potential upside of 55.20%. Given EUDA Health’s higher possible upside, analysts clearly believe EUDA Health is more favorable than Phreesia.

Institutional & Insider Ownership

4.3% of EUDA Health shares are held by institutional investors. Comparatively, 92.1% of Phreesia shares are held by institutional investors. 5.2% of Phreesia shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares EUDA Health and Phreesia’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
EUDA Health N/A N/A N/A
Phreesia 1.85% 5.13% 3.12%

Volatility and Risk

EUDA Health has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Comparatively, Phreesia has a beta of 0.87, indicating that its share price is 13% less volatile than the S&P 500.

Summary

Phreesia beats EUDA Health on 10 of the 12 factors compared between the two stocks.

About EUDA Health

(Get Free Report)

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.

About Phreesia

(Get Free Report)

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

Receive News & Ratings for EUDA Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EUDA Health and related companies with MarketBeat.com's FREE daily email newsletter.